Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RuvB-like ATPase 2 (RUVBL2) is a highly conserved AAA+ ATPase and helicase that functions as an essential subunit of several nuclear protein complexes, notably the INO80 and NuA4 chromatin remodeling complexes and the R2TP chaperone. It forms hexameric or dodecameric assemblies, often with its paralog RUVBL1, and is critical for ATP-dependent processes such as DNA unwinding, chromatin remodeling, and transcription regulation. RUVBL2 is a coactivator of RNA polymerase II–dependent transcription and supports the assembly and function of large macromolecular complexes involved in cell cycle progression, DNA repair, and oncogenic transformation[1][2][3][4][5]. RUVBL2 is overexpressed in a variety of cancers, where it regulates oncogene and proto-oncogene function; consequently, it is being investigated as a cancer therapeutic target. Cordycepin has been identified as a small molecule inhibitor of RUVBL2, offering proof of druggability[3]. Given its broad cellular functions and essentiality, therapeutic targeting of RUVBL2 requires careful consideration of potential safety liabilities.
Inhibition of ATPase activity leading to impaired chromatin remodeling and transcriptional regulation Disruption of multi-protein complex assembly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RuvB-like ATPase 2 (RUVBL2).